MetaCap

Zhengye Biotechnology Holding Limited Class A Company Profile

NASDAQ: ZYBTHealthcareDrug Manufacturers - Specialty & GenericUSD

1.15-0.0101 (-0.87%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Pre-market: 1.19 +3.49%

Zhengye Biotechnology at a glance

Zhengye Biotechnology Holding Limited Class A (NASDAQ: ZYBT) is a Drug Manufacturers - Specialty & Generic company in the Healthcare sector headquartered in Jilin, China. Zhengye Biotechnology is led by Mr. Songlin Song and employs about 269 people. The company's shares have traded publicly since 2025.

At a market capitalization of $55.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001975641, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Zhengye Biotechnology do?

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in the People's Republic of China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs, as well as monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. It also develops vaccines for household animals, including rabies vaccine and Strain Flury LEP for dogs. In addition, the company exports its products to Vietnam, Pakistan, and Egypt. It serves direct-end customers, including livestock farmers and local governments; and domestic distributors and exporting distributors. The company was incorporated in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Business description based on the company's public filings.

Company information

Legal name
Zhengye Biotechnology Holding Limited Class A
Ticker
NASDAQ: ZYBT
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Songlin Song
Employees
269
Headquarters
No.1 Lianmeng Road, Jilin, China
Phone
86 432 6304 7008
IPO year
2025
Market cap
$54.97M
SEC CIK
0001975641

Companies similar to Zhengye Biotechnology

ZYBT peer companies
CompanyPrice% ChgMarket capCompare
TLPHTalphera Inc.1.08+2.86%$56.06Mvs ZYBT
SCYXSCYNEXIS Inc.4.22-11.72%$41.99Mvs ZYBT
CPHIChina Pharma Holdings Inc.0.96+12.94%$41.30Mvs ZYBT
IXHLIncannex Healthcare Inc.3.20+0.63%$40.14Mvs ZYBT
INCRIntercure Ltd.5.03-1.95%$75.47Mvs ZYBT
RMTIRockwell Medical Inc.8.02-2.43%$32.32Mvs ZYBT
SHPHShuttle Pharmaceuticals Holdings Inc.5.55+17.83%$26.44Mvs ZYBT
OPTHOptimi Health Corp.4.090.00%$23.39Mvs ZYBT

Related